Mosaic Mutations May Not Be Rare
By Anna Azvolinsky,
The Scientist
| 06. 08. 2015
Untitled Document
Most novel mutations in an individual are thought to originate in the germline. Other mutations, somatic mosaic mutations—which are only present in a subset of a person’s cells—can either be passed down from a parent or originate during early development. Such mosaic mutations were thought to be fairly rare, but according to a study published today (June 5) in The American Journal of Human Genetics, they may contribute to as much as 6.5 percent of an individual’s genomic variation. If confirmed, the results could affect how researchers estimate a person’s risk of passing disease-linked alleles on to their children.
The findings “highlight that mosaicism may be more common than we had appreciated so far,” geneticist Anne Goriely of the University of Oxford wrote in an e-mail to The Scientist. “The main value of the present study is an attempt to quantify this process,” added Goriely, who was not involved in the work.
Mosaicism can result when a de novo mutation arises after an embryo is formed. Using newer, more sensitive sequencing technologies, researchers have recently...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Katrina Miller, The New York TImes | 02.05.2026
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal jurisdiction of an American Indian nation, on the Cheyenne River Sioux Reservation in Eagle Butte, S.D.
NativeBio participated in a ...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...